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In this study, we investigated the changes of the serum levels of thyroid 
hormones including Thyroxine (T4), Triiodothyronine (T3), T3 resin uptake and 
Thyroid stimulating hormone (TSH) in epileptic children during treatment with 
anti-epileptic drugs (AEDs) including carbamazepine (CBZ), primidone (PRM), 
phenobarbital and valproic acid (VPA).
Materials and Methods
This study consisted of four case-series comparisons, was conducted on 115 
epileptic children (37 girls and 78 boys with an age range between 2 months 
and 15 years, mean: 62.06 ± 44.97 months). These children were divided into 
4 groups who took either phenobarbital (n=29), PRM (n=28), CBZ (n=29), or 
VPA (n=29) for 3 months. Thyroid hormone levels (T3, T3 resin uptake, T4 and 
TSH) were measured at the beginning and three months after starting the study.
Results
At first, all patients were euthyroid and there were no clinical or laboratory 
findings suggestive of hypothyroidism.  Regarding thyroid hormones before and 
after the administration of phenobarbital, carbamazepine, valproic acid and 
primidone, there were no significant changes in serum T3, T4, T3 resin uptake 
and TSH levels. 
Conclusions
Our findings showed that short term therapy with phenobarbital, carbamazepine, 
valproic acid and primidone had no effect on thyroid function tests.
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Introduction
Epilepsy describes a state in which a person has revolving seizures due to a chronic-
underlying process. The prevalence of epilepsy has been estimated at 5–10 patient 
per 1000 (1). Older antiepileptic(AEDs) drugs such as phenytoin, valproic acid, 
carbamazepine, phenobarbital and ethosuximide are generally used as the first-line 
therapy for most seizure disorders (2). Effects on the thyroid hormone balance are of 
early importance in the side effects of AEDs on the endocrine system (3).
The prime study around the effects of AEDs on thyroid gland was made in 1961 
by Oppenheimer et al who met a downfall in iodine bound to serum proteins and 
a disorder in T4 secretion from thyroxin binding globulin (TBG) in adults taking 
phenytoin (4). AEDs with an enzyme-inducing activity and distinct protein binding 
activity, such as diphenylhydantoin, carbamazepine (5), and oxcarbazepine, 
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typically induce diminished levels of thyroxin and free 
thyroxin, but have transitive effects on levels of TSH, 
T3, free T3 and TBG (6-9). Among  studies seeking the 
consequences of AEDs on thyroid hormones, the best and 
most diverse results are obtained with valproate which 
does not alter the thyroid hormone levels; however, later 
studies showed that valproate could cause subclinical 
hypothyroidism (10-14).
Liewendahl et al (15), first reported a reduction in free 
thyroxin (FT4)and T4 concentrations, with TSH levels, 
remained unchanged with Carbamazepine (CBZ) 
treatment. From this study, multiple reports with the goal 
to assess serum thyroid hormone balance in children 
receiving long-term therapy with Carbamazepine were 
suggested (16-18). Isojarvi et al (19) and Eiris-Punal et 
al (20) recommended that CBZ may induce subclinical 
hypothyroidism. A distinct downfall in thyroid hormone 
serum levels is present in all patients who receive 
Phenytoin (PHT) (7, 20).
There are few reports regarding the relationship between 
barbiturates and thyroid hormones levels (21). Cavlieri 
et al (22) declared that in hyperthyroid patients with 
Graves disease on phenobarbital (PB) treatment, , the 
fact that TSH does not increase shows that the average 
effect of therapeutic levels of PB on thyroid hormone 
metabolism is fairly gentle (21).
Lots of studies have reported altered thyroid function 
(especially low FT4) in patients with epilepsy during 
treatment with Valproic Acid (VPA), but the outcomes 
were controversial: normal or increased serum levels of 
thyroid hormones and TSH have been announced (23).
In this study, we investigated the changes of serum levels 
of Free T4 , T3, T3 resin uptake (T3RU) and TSH in 
epileptic children during treatment with carbamazepine, 
Primidone, phenobarbital and valproate, before and 3 
months after prescription.
The aim of this study was to investigate the effects of 
four AEDs on thyroid function tests. 
 
Materials and Methods 
This analytical cross sectional study was performed 
between Sep 2008 and Sep 2009 in pediatric neurology 
outpatient clinic of Baqyiatallah Hospital. A total of 115 
children with epilepsy were consecutively divided into 
four groups who were taking either phenobarbital, PRM, 
CBZ, or VPA because of generalized or partial epilepsy. 
They included 37 girls and 78 boys with an age range 
of 2 months to 15 years with a mean age of 62.06 ± 
44.97 months. The exclusion criteria were as follows: 
abnormal neurologic examination, malformed cerebral 
computed tomography (CT) and/or magnetic resonance 
imaging (MRI), liver or kidney disease, thyroid disease 
or endocrinopathies, using contraindicated remedies and 
genetic or chromosomal abnormalities. The patients with 
uncontrolled seizures, those who received a multi-drug 
treatment regimen and /or those with chronic diseases 
known to disturb thyroid function were excluded as well.
Twenty-nine children were treated with VPA, 29 with 
CBZ, 29 with Phenobarbital and 28 with PRM. The  type 
of epilepsy was classified as stated by the  proposals of 
the International League Against Epilepsy (25). The 
AEDs were chosen by a pediatric neurologist depending 
on the age of the patients and the type of epilepsy; 
CBZ was preferred for the therapy of patients with 
partial seizures with or without generalization, VPA 
was preferred for patients with primary generalized 
seizures (including absence and myoclonic seizures), 
Phenobarbital and PRM were preferred for children 
with generalized or partial seizures under age 3 due to 
better serum levels and lower side effects. Prescribed 
doses of CBZ and VPA were within therapeutic limits: 
20-30 mg/kg/day(200-600 mg/day). Prescribed doses 
of Phenobarbital and PRM were within the therapeutic 
range: 3-5 mg/kg/day and 20 mg/kg/day, respectively. 
No other medications known to disturb thyroid function 
were prescribed. 
Serum thyroxine (T4), triiodothyronine (T3), T3 resin 
uptake and thyroid-stimulating hormone concentrations 
were measured in all patients  before and 3 months 
after the treatment commenced with antiepileptic drugs. 
The results of computations were inspected by an 
endocrinologist to evaluate thyroid function status.
Data with a normal distribution were reported as mean 
± SD, whereas data with a non-normal distribution were 
summarized as median and range. For statistical analysis 
of variables indicating a normal distribution, we used 
analysis of variance, with the Student t test for subsequent 
pair wise comparisons. For statistical analysis of 
variables indicating a non-normal distribution, we used 
the Mann-Whitney U test and Pearson and Spearman 
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rank correlations as well. Data was analyzed with SPSS 
software edition 14. Estimated thyroid dysfunction was 
based on chi-Score test. P< 0.05 and CI: 95 % were 
considered significant. This study was approved by the 
Ethics Committee of Baqyiatallah University of Medical 
Sciences. A written informed consent was obtained from 
all parents prior to initiation of the study.
Limitations of study: Few patients were excluded from 
the study due to their need for multiple AEDs. Five 
patients were excluded from the study due to thyroid 
dysfunction before starting the AEDs.  
Results
At the beginning of the study, all 115 patients were 
clinically and paraclinically euthyroid. Twenty nine 
patients, 55.2% male and 44.1 %females, (mean age: 
86.75 ± 42.07 months) received VPA. There was no 
significant difference in serum T3, T4, T3RU and TSH 
before and after prescription (p>0.05) but T3, T4, T3RU 
levels mildly decreased 3 months after starting VPA. 
Age of these patients was significantly higher than PRM 
and PB groups (p<0.05).
There were 29 patients in the carbamazepine group 
(75.9%  male and 24.1% female, mean age: 78.27 ± 45.38 
months). Patients receiving carbamazepine showed no 
significant difference in serum T3, T4, T3RU and TSH 
levels before and after prescription (P>0.05), but their 
ages were remarkably higher than PRM and PB groups 
(p<0.05). This was predictable because PB & PRM are 
administered more for children below 3 years of age but 
CBZ & VPA are mostly administered for children above 
the age of 3 years.
Twenty-nine cases received Phenobarbital (75.9% male 
and 24.1% female, mean age: 38 ± 28.75 months). 
Patients receiving Phenobarbital showed no significant 
variation in serum T3, T4, T3RU and TSH level before 
and 3 months after prescription (P>0.05). Their ages 
were remarkably lower than CBZ and VPA groups. 
Twenty-eight cases (64.3% male and 35.7% female, 
mean age 35.37 ± 31.85 months) received Primidone. 
They had a notably lower mean age than CBZ and VPA 
groups (p<0.05), but there were no significant differences 
in serum T3, T4, T3Ru and TSH levels before and 3 
months after prescription (p>0.05).
Number and age of the patients receiving PB, PRM, 
CBZ, and VPA are presented in Table 1.
Serum T3, T4, T3RU and TSH values before and after 
the medication are shown in Table 2 and 3, respectively.
Discussion
In this study, we evaluated the impressions of single-drug 
therapy with 4 widely used conventional antiepileptic 
drugs (carbamazepine, pirimidon, phenobarbital, and 
valproate) on the thyroid function of epileptic children. 
The effects of AEDs on thyroid functions are recognized 
for a long time; however, a general finding does not exist 
yet. In humans, only free forms of thyroid hormones 
are functional, FT4, FT3, T3 RU and TSH levels are 
used by most of the investigators (9, 26, 28). Among 
investigations on the effects of AEDs on thyroid 
hormones, the most incoherent results are obtained with 
Valproate. It has been suggested in some researches that 
valproate does not alter thyroid hormone levels because 
it is not an inducing drug (19,27). 
Phenobarbital is one of the drugs inducing the hepatic 
microsomal enzyme system. Phenobarbital effects 
on thyroid functions are similar to phenytoin and 
carbamazepine. There is no agreement among the 
researchers on how phenobarbital affects the thyroid 
(4,7,12), Haidukewitych and Rodin (27) observed a 
notably low serum T4 and FT4 index in 58 cases receiving 
Phenobarbital but reported that patients maintained their 
euthyroid state. Rousso et al (29) assessed serum T4, 
FT4 index (T3 uptake × total T4 )  and TSH levels in 110 
children on long-term Phenobarbital, carbamazepine 
and phenytoin therapy and noted low serum T4 levels 
and FT4 index but no change in TSH concentrations 
in Phenobarbital receiving patients. They also reported 
significantly high serum TSH levels but significantly low 
serum T4 and FT4 in children receiving carbamazepine. 
Yüksel et a (30) reported a significant reduction in 
serum FT4 and FT3 levels in ten children receiving 
Phenobarbital compared to the control group; they also 
reported a significant decline in serum FT4 and FT3 
levels in 11 children receiving carbamazepine compared 
to the control group. Deda et al (26) conducted a study 
on 20 pediatric cases receiving Phenobarbital and 15 
children on Phenytoin but found no significant difference 
in serum FT4, FT3 and TSH levels when compared to 
the control group. 
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Isojarvi et al (19) evaluated cases who were receiving 
carbamazepine and phenytoin, and reported a significant 
reduction in T4 and FT4 but no alteration in T3 and 
TSH levels. They also described 24 carbamazepine 
receiving cases with a significant reduction of T4 and 
FT4 but unchanged T3 and TSH levels in 1992; they 
reported that there was no significant difference between 
valproate users and the control groups (19). Ericsson et 
al. (31) reported normal TSH but elevated serum T3 and 
T4 levels. There are no contradictions regarding thyroid 
hormones in other studies (27,30).
Strandjord et al (32) reported that in 42 cases, serum T3, 
T4 and FT4 levels significantly diminished after receiving 
carbamazepine for 8-24 months compared to the control 
group. They also pursued 12 cases for 1-5 months and 
found that their serum T3 and TSH concentrations did 
not change, but their serum T4 concentrations notably 
diminished in comparison with the pre-treatment levels. 
Tiihonen et al (33), as well as Rootwelt et al (34), found 
that in the first 4-20 days of treatment, TSH levels 
increased and then decreased quickly to normal levels.
Castro-Gago et al (2) investigated 23 cases with a mean 
age of 7.5 years who received carbamazepine for a 
mean duration of 17.82 months and found no significant 
difference in serum FT3 and TSH levels but significant 
low serum FT4 levels compared to the control group. 
They also found no difference in thyroid hormone levels 
in patients receiving valproate as compared to the control 
group. 
In our study on 115 cases with a mean age of 62.06±44.97 
months who received AED for 3 months, we noted 
no significant changes in thyroid hormones but mild 
alterations in some variants.
In conclusion, short term administration of these AEDs 
by children does not appear to increase the risk of thyroid 
dysfunction. We suggest investigators to re-conduct this 
study with more patients and a longer follow-up period. 
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Table 1: Patients  mean age in different groups
   
   Medication Phenobarbital Primidone Valproate Carbamazepine
    Number 29 28 29 29
Mean age (months) 38 ± 28.55 35.37 ± 31.85 86.75± 42.07 87.27±45.28
Table 2: Thyroid hormones levels before AED prescription.
          TSH (micIU/ml), T3 (ng/ml), T4 (ng/ml), T3RU (%)
Valproate Carbamazepine Primidone Phenobarbital
TSH 2.71±1.42 2.78 ± 0.29 2.26 ± 1.09 2.48 ± 1.15
T3 1.47±0.30 1.79±0.21 1.64± 0.28 1. 53± 0.16
T4 8.14±1.91 9.02 ± 2.54 9.15± 2.17 8.57 ± 1.71
T3RU 30.01±1.83 30.01± 1.13 29.22±1.34 31.8±1.26
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Table 3. Thyroid hormones levels after AED prescription.
 TSH (micIU/ml), T3 (ng/ml), T4 (ng/ml), T3RU (%)
Valproate Carbamazepine Primidone Phenobarbital
TSH 2.97±1.63 2.97 ± 1.23 2.18 ± 1.3 2.72 ± 1.68
T3 1.23±0.42 1.47±0.38 1.71± 0.27 1. 4± 0.54
T4 7.88±1.81 8.24 ± 2.7 8.67± 2.06 8.3 ± 2.65
T3RU 28.95±1.35 30.28± 2.04 30.15±2.49 31.8±1.26
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